A Randomised Controlled Trial of the Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy) Compared with 0.25% Desoximetasone Cream (Topicorte) for the Treatment of Scalp Psoriasis
Objective: To compare the efficacy and safety of a generic desoximetasone cream (Topoxy) with the reference form, Topicorte, for the treatment of scalp psoriasis. Methods: A randomised, double-blind, controlled study was conducted. Altogether, 105 patients with psoriasis lesions covering more than...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mahidol University
2020-05-01
|
Series: | Siriraj Medical Journal |
Subjects: | |
Online Access: | https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/241932 |
id |
doaj-f625f5728c8a4588a418bbc38923de16 |
---|---|
record_format |
Article |
spelling |
doaj-f625f5728c8a4588a418bbc38923de162021-08-13T09:45:13ZengMahidol UniversitySiriraj Medical Journal2228-80822020-05-0172510.33192/Smj.2020.50241932A Randomised Controlled Trial of the Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy) Compared with 0.25% Desoximetasone Cream (Topicorte) for the Treatment of Scalp PsoriasisLeena Chularojanamontri0Narumol Silpa-archa1Pichanee Chaweekulrat2Chayanee Likitwattananurak3Puncharas Weerasubpong4Natchaya Junsuwan5Norramon Charoenpipatsin6Chanisada Wongpraparut 7Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Objective: To compare the efficacy and safety of a generic desoximetasone cream (Topoxy) with the reference form, Topicorte, for the treatment of scalp psoriasis. Methods: A randomised, double-blind, controlled study was conducted. Altogether, 105 patients with psoriasis lesions covering more than 10% of the scalp were randomised into three groups. The first, second and third groups received a placebo, Topoxy and Topicorte, respectively. The scalp psoriasis severities were assessed at weeks 0, 2, 4 and 8, using the Investigator Global Assessment (IGA) scale and Total Sign Score (TSS). The safety profiles of the products were assessed by the patients and physicians. Results: Topoxy and Topicorte were significantly more effective than the placebo in achieving at least a two-grade improvement in the IGA score from baseline at weeks 2, 4 and 8, and there were no significant differences between Topoxy and Topicorte. The TSS of both creams were significantly lower than that of the placebo at weeks 2, 4 and 8. All patients tolerated well to the therapy. Conclusion: Topoxy and Topicorte had comparable efficacies for scalp psoriasis., The medications were superior to the placebo in all parameters, and had a good safety profile. https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/241932Desoximetasone creamscalp psoriasistopicortetopoxy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Leena Chularojanamontri Narumol Silpa-archa Pichanee Chaweekulrat Chayanee Likitwattananurak Puncharas Weerasubpong Natchaya Junsuwan Norramon Charoenpipatsin Chanisada Wongpraparut |
spellingShingle |
Leena Chularojanamontri Narumol Silpa-archa Pichanee Chaweekulrat Chayanee Likitwattananurak Puncharas Weerasubpong Natchaya Junsuwan Norramon Charoenpipatsin Chanisada Wongpraparut A Randomised Controlled Trial of the Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy) Compared with 0.25% Desoximetasone Cream (Topicorte) for the Treatment of Scalp Psoriasis Siriraj Medical Journal Desoximetasone cream scalp psoriasis topicorte topoxy |
author_facet |
Leena Chularojanamontri Narumol Silpa-archa Pichanee Chaweekulrat Chayanee Likitwattananurak Puncharas Weerasubpong Natchaya Junsuwan Norramon Charoenpipatsin Chanisada Wongpraparut |
author_sort |
Leena Chularojanamontri |
title |
A Randomised Controlled Trial of the Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy) Compared with 0.25% Desoximetasone Cream (Topicorte) for the Treatment of Scalp Psoriasis |
title_short |
A Randomised Controlled Trial of the Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy) Compared with 0.25% Desoximetasone Cream (Topicorte) for the Treatment of Scalp Psoriasis |
title_full |
A Randomised Controlled Trial of the Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy) Compared with 0.25% Desoximetasone Cream (Topicorte) for the Treatment of Scalp Psoriasis |
title_fullStr |
A Randomised Controlled Trial of the Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy) Compared with 0.25% Desoximetasone Cream (Topicorte) for the Treatment of Scalp Psoriasis |
title_full_unstemmed |
A Randomised Controlled Trial of the Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy) Compared with 0.25% Desoximetasone Cream (Topicorte) for the Treatment of Scalp Psoriasis |
title_sort |
randomised controlled trial of the efficacy and safety of 0.25% desoximetasone cream (topoxy) compared with 0.25% desoximetasone cream (topicorte) for the treatment of scalp psoriasis |
publisher |
Mahidol University |
series |
Siriraj Medical Journal |
issn |
2228-8082 |
publishDate |
2020-05-01 |
description |
Objective: To compare the efficacy and safety of a generic desoximetasone cream (Topoxy) with the reference form, Topicorte, for the treatment of scalp psoriasis.
Methods: A randomised, double-blind, controlled study was conducted. Altogether, 105 patients with psoriasis lesions covering more than 10% of the scalp were randomised into three groups. The first, second and third groups received a placebo, Topoxy and Topicorte, respectively. The scalp psoriasis severities were assessed at weeks 0, 2, 4 and 8, using the Investigator Global Assessment (IGA) scale and Total Sign Score (TSS). The safety profiles of the products were assessed by the patients and physicians.
Results: Topoxy and Topicorte were significantly more effective than the placebo in achieving at least a two-grade improvement in the IGA score from baseline at weeks 2, 4 and 8, and there were no significant differences between Topoxy and Topicorte. The TSS of both creams were significantly lower than that of the placebo at weeks 2, 4 and 8. All patients tolerated well to the therapy.
Conclusion: Topoxy and Topicorte had comparable efficacies for scalp psoriasis., The medications were superior to the placebo in all parameters, and had a good safety profile.
|
topic |
Desoximetasone cream scalp psoriasis topicorte topoxy |
url |
https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/241932 |
work_keys_str_mv |
AT leenachularojanamontri arandomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT narumolsilpaarcha arandomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT pichaneechaweekulrat arandomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT chayaneelikitwattananurak arandomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT puncharasweerasubpong arandomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT natchayajunsuwan arandomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT norramoncharoenpipatsin arandomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT chanisadawongpraparut arandomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT leenachularojanamontri randomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT narumolsilpaarcha randomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT pichaneechaweekulrat randomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT chayaneelikitwattananurak randomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT puncharasweerasubpong randomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT natchayajunsuwan randomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT norramoncharoenpipatsin randomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis AT chanisadawongpraparut randomisedcontrolledtrialoftheefficacyandsafetyof025desoximetasonecreamtopoxycomparedwith025desoximetasonecreamtopicorteforthetreatmentofscalppsoriasis |
_version_ |
1721208906646028288 |